Your browser doesn't support javascript.
loading
Genetic determinants of micronucleus formation in vivo.
Adams, D J; Barlas, B; McIntyre, R E; Salguero, I; van der Weyden, L; Barros, A; Vicente, J R; Karimpour, N; Haider, A; Ranzani, M; Turner, G; Thompson, N A; Harle, V; Olvera-León, R; Robles-Espinoza, C D; Speak, A O; Geisler, N; Weninger, W J; Geyer, S H; Hewinson, J; Karp, N A; Fu, B; Yang, F; Kozik, Z; Choudhary, J; Yu, L; van Ruiten, M S; Rowland, B D; Lelliott, C J; Del Castillo Velasco-Herrera, M; Verstraten, R; Bruckner, L; Henssen, A G; Rooimans, M A; de Lange, J; Mohun, T J; Arends, M J; Kentistou, K A; Coelho, P A; Zhao, Y; Zecchini, H; Perry, J R B; Jackson, S P; Balmus, G.
Affiliation
  • Adams DJ; Wellcome Sanger Institute, Cambridge, UK. da1@sanger.ac.uk.
  • Barlas B; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.
  • McIntyre RE; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Salguero I; Wellcome Sanger Institute, Cambridge, UK.
  • van der Weyden L; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
  • Barros A; Wellcome Sanger Institute, Cambridge, UK.
  • Vicente JR; Wellcome Sanger Institute, Cambridge, UK.
  • Karimpour N; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
  • Haider A; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.
  • Ranzani M; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Turner G; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.
  • Thompson NA; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Harle V; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.
  • Olvera-León R; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Robles-Espinoza CD; Wellcome Sanger Institute, Cambridge, UK.
  • Speak AO; Wellcome Sanger Institute, Cambridge, UK.
  • Geisler N; Wellcome Sanger Institute, Cambridge, UK.
  • Weninger WJ; Wellcome Sanger Institute, Cambridge, UK.
  • Geyer SH; Wellcome Sanger Institute, Cambridge, UK.
  • Hewinson J; Wellcome Sanger Institute, Cambridge, UK.
  • Karp NA; Laboratorio Internacional de Investigación Sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, México.
  • Fu B; Wellcome Sanger Institute, Cambridge, UK.
  • Yang F; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
  • Kozik Z; Division of Anatomy, MIC, Medical University of Vienna, Wien, Austria.
  • Choudhary J; Division of Anatomy, MIC, Medical University of Vienna, Wien, Austria.
  • Yu L; Wellcome Sanger Institute, Cambridge, UK.
  • van Ruiten MS; Wellcome Sanger Institute, Cambridge, UK.
  • Lelliott CJ; Wellcome Sanger Institute, Cambridge, UK.
  • Del Castillo Velasco-Herrera M; Wellcome Sanger Institute, Cambridge, UK.
  • Verstraten R; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London, UK.
  • Bruckner L; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London, UK.
  • Henssen AG; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London, UK.
  • Rooimans MA; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • de Lange J; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Mohun TJ; Wellcome Sanger Institute, Cambridge, UK.
  • Arends MJ; Wellcome Sanger Institute, Cambridge, UK.
  • Kentistou KA; Wellcome Sanger Institute, Cambridge, UK.
  • Coelho PA; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Zhao Y; Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.
  • Zecchini H; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Perry JRB; Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.
  • Jackson SP; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Balmus G; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nature ; 627(8002): 130-136, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38355793
ABSTRACT
Genomic instability arising from defective responses to DNA damage1 or mitotic chromosomal imbalances2 can lead to the sequestration of DNA in aberrant extranuclear structures called micronuclei (MN). Although MN are a hallmark of ageing and diseases associated with genomic instability, the catalogue of genetic players that regulate the generation of MN remains to be determined. Here we analyse 997 mouse mutant lines, revealing 145 genes whose loss significantly increases (n = 71) or decreases (n = 74) MN formation, including many genes whose orthologues are linked to human disease. We found that mice null for Dscc1, which showed the most significant increase in MN, also displayed a range of phenotypes characteristic of patients with cohesinopathy disorders. After validating the DSCC1-associated MN instability phenotype in human cells, we used genome-wide CRISPR-Cas9 screening to define synthetic lethal and synthetic rescue interactors. We found that the loss of SIRT1 can rescue phenotypes associated with DSCC1 loss in a manner paralleling restoration of protein acetylation of SMC3. Our study reveals factors involved in maintaining genomic stability and shows how this information can be used to identify mechanisms that are relevant to human disease biology1.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genomic Instability / Micronuclei, Chromosome-Defective Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nature Year: 2024 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genomic Instability / Micronuclei, Chromosome-Defective Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nature Year: 2024 Type: Article Affiliation country: United kingdom